Trial Search Results
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
The PRESERVE-Zenith® Iliac Branch System Clinical Study is a clinical trial to collect confirmatory safety and effectiveness data on the Zenith® Branch Endovascular Graft-Iliac Bifurcation System. This system is made up of two devices: the Zenith® Branch Endovascular Graft-Iliac Bifurcation and the ConnectSX™ covered stent in the treatment of aorto-iliac and iliac aneurysms
Stanford is currently not accepting patients for this trial.
Lead Sponsor:
Cook Group Incorporated
Stanford Investigator(s):
Intervention(s):
- Device: Zenith® Branch Endovascular Graft-Iliac Bifurcation System
Eligibility
Inclusion Criteria:
- An aortioiliac or iliac aneurysm
- An unsuitable distal sealing site for a traditional Zenith iliac leg graft within the
common lilac artery
Exclusion Criteria:
- Less than 18 years of age
- Inability or refusal to give informed consent
- Disease considerations that would compromise patient safety or study outcomes
- Unsuitable arterial anatomy
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
All
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Not Recruiting